CX3CR1 and systemic sclerosis: Hasegawa et al. have previously described an increased expression of CX3CR1 in circulating CD8 T cells of SSc patients with diffuse cutaneous form compared with controls, whereas no difference was found between SSc patients with limited and diffuse cutaneous involvement (17).